Phenylpropanolamine-induced psychoses
Widerlöv, E.
Lakartidningen 76(49): 4529-4530
1979
ISSN/ISBN: 0023-7205 PMID: 544991 Document Number: 144368
Document emailed within 1 workday
Related Documents
Ekeberg, O.; Løvgren, J. 1983: Disulfiram-induced psychoses Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 103(19-21): 1444-1445Bron, B. 1982: Drug-induced psychoses Der Nervenarzt 53(11): 617-627
Hurlbut, K.M. 1991: Drug-induced psychoses Emergency Medicine Clinics of North America 9(1): 31-52
Vaindrukh, F.A.; Nazarov, K.N. 1973: Constitution and psychoses (body build and psychoses) (review of the literature) Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 73(1): 140-148
Wakamatsu, N. 1985: Psychopathologic studies of analeptic amine-induced psychoses Seishin Shinkeigaku Zasshi 87(6): 373-396
Lungershausen, E. 1984: Differential diagnosis of so-called drug-induced and endogenous psychoses Fortschritte der Medizin 102(45): 1149-1152
Baer, G.; Parkas, P. 1981: Ketamine-induced psychopathological changes in normal volunteers during conditions used for experimental psychoses Der Anaesthesist 30(5): 251-256
Goudemand, M.; Goudemand, J.; Goudemand-Joubert, C.; Parquet, P.J. 1981: Heredity and childhood psychoses : histocompatibility antigens (HLA a and B) and early onset childhood psychoses Acta Psychiatrica Belgica 81(1): 57-71
Silverman, H.I.; Shargel, L. 1986: Phenylpropanolamine American Family Physician 34(4): 39-42
Traynelis, V.C.; Brick, J.F. 1986: Phenylpropanolamine and vasospasm Neurology 36(4): 593-594
Lake, C.R.; Rosenberg, D.; Quirk, R. 1990: Phenylpropanolamine and caffeine use among diet center clients International Journal of Obesity 14(7): 575-582
Bende, M.; Andersson, K.E.; Johansson, C.J.; Sjögren, C.; Svensson, G. 1985: Vascular effects of phenylpropanolamine on human nasal mucosa Rhinology 23(1): 43-48
Lönnerholm, G.; Grahnén, A.; Lindström, B. 1984: Steady-state kinetics of sustained-release phenylpropanolamine International Journal of Clinical Pharmacology Therapy and Toxicology 22(1): 39-41
Ryu, S.J.; Lin, S.K. 1995: Cerebral arteritis associated with oral use of phenylpropanolamine: report of a case Journal of the Formosan Medical Association 94(1-2): 53-55
Thomas, M.; Scheinmann, N. 1977: Evanescent toxic thyroid adenoma. Possible role of phenylpropanolamine La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 53(34-35): 1863-1865
Lehtonen, T.; Rannikko, S.; Lindell, O.; Talja, M.; Wuokko, E.; Lindskog, M. 1986: The effect of phenylpropanolamine on female stress urinary incontinence Annales Chirurgiae et Gynaecologiae 75(4): 236-241
Larson, W.L.; Rogers, A. 1986: Overdosage from phenylpropanolamine: experience of the Hennepin Regional Poison Center Veterinary and Human Toxicology 28(6): 546-548
Castellani, S. 1985: Catatonia associated with phenylpropanolamine overdose and fluphenazine treatment: case report Journal of Clinical Psychiatry 46(7): 288-289
Morgan, J.P.; Funderburk, F.R. 1990: Invited commentary: phenylpropanolamine and the medical literature: a thorough reading is required International Journal of Obesity 14(7): 569-574
Jessen, T.G.; Martinez, T.T. 1987: The effect of phenylpropanolamine and amphetamine on fighting behavior and weight change in mice Proceedings of the Western Pharmacology Society 30: 419-422